Bayesian Capital Management’s Magellan Health Services, Inc. MGLN Stock Holding History

Bayesian Capital Management’s Portfolio MGLN Stock Details MGLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,900	Closed	-$280K	–	889
2017 Q4	$280K	Buy	+2,900	New	+$257K	0.06%	428
2017 Q1	–	Sell	-7,187	Closed	-$541K	–	760
2016 Q4	$541K	Buy	+7,187	New	+$460K	0.13%	291

Other funds holding MGLN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Bayesian Capital Management's MGLN Position: Q1 2018 in Review

Bayesian Capital Management sold out of Magellan Health Services, Inc. (MGLN) in Q1 2018, closing a stake of 2,900 shares — an estimated $280K sold.

Bayesian Capital Management first reported a position in MGLN in Q4 2016 and held it in 2 quarters. The position peaked at $541K in Q4 2016. 240 funds tracked by Wall St. Rank hold MGLN as of Q1 2018.

Bayesian Capital Management reported no remaining Magellan Health Services, Inc. position as of Q1 2018 after selling out during the quarter.
Bayesian Capital Management sold 2,900 Magellan Health Services, Inc. shares in Q1 2018, an estimated $280K.
Bayesian Capital Management first reported a position in Magellan Health Services, Inc. in Q4 2016 and held it in 2 quarters.
Bayesian Capital Management's Magellan Health Services, Inc. position peaked at $541K in Q4 2016.
240 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2018.

Based on Bayesian Capital Management's 13F filing for Q1 2018, filed 15 May 2018.